Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01054560 · ClinicalTrials.gov registry record · NA
SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study
A NA study, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT01054560 is a NA study that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 144 participants.
The verdict
NCT01054560, a NA study, has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate substantial equivalence of the SOLITAIRE™ FR Revascularization Device (SOLITAIRE™ Device) with a legally marketed device, MERCI Retrieval System® (MERCI® Device). The study will demonstrate safety and efficacy of the SOLITAIRE™ Device in subjects requiring mechanical thrombectomy diagnosed with acute ischemic stroke.
Interventions
- DEVICE SOLITAIRE™ Device
- DEVICE MERCI® Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01054560
The ClinicalTrials.gov registry entry for NCT01054560 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SOLITAIRE™ Device is the first listed.
NCT01054560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01054560 about?
NCT01054560 is a clinical study titled "SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study". The purpose of this study is to demonstrate substantial equivalence of the SOLITAIRE™ FR Revascularization Device (SOLITAIRE™ Device) with a legally marketed device, MERCI Retrieval System® (MERCI® Device). The study will demonstrate safety and efficacy of the SOLITAIRE™ Device in subjects requiring...
What is the current status of trial NCT01054560?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2010-01. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01054560?
The interventions under investigation include: SOLITAIRE™ Device (DEVICE), MERCI® Device (DEVICE).
Who is sponsoring clinical trial NCT01054560?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.